Disclosure - Responsible Transparency / 2016
Disclosures by KEFEA Members:
(Also click on the following hyperlinks for the Methodology statement and the Disclosure Report for Hospira, a Pfizer company)
( Also click on the following hyperlinks for the Methodology Statement and the Report in English )
(No transfers of value took place in Cyprus in 2016)
Disclosures by other EFPIA members operating in Cyprus*:
- LIFEPHARMA (Z.A.M.) LTD representing ABBVIE
- G.A. STAMATIS & CO. LTD representing SANOFI PASTEUR S.A.
- G.A. STAMATIS & CO. LTD representing Roche (Hellas) S.A.
- C.G. PAPALOISOU representing Merck
- C.G. PAPALOISOU representing Recordati
- NOVAGEM LTD representing Bayer
- LUNDBECK HELLAS S.A.
- Varnavas Hadjipanayis Ltd representing Janssen Pharmaceuticals
- Varnavas Hadjipanayis Ltd representing Novo Nordisk
- MENARINI HELLAS A.E
- CPO Ltd representing Boehringer Ingelheim
* Hypertext links in this section of the website will direct you to websites containing the disclosure of transfers of value as required by the KEFEA Code of Conduct. These websites are not under the control of KEFEA. When you activate any of these, you will leave this website. KEFEA accepts no responsibility or liability for the accuracy of the content of any such websites and makes no representation or warranty (express or implied) as to the information contained therein.’’